Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven-Figure Retirement
The S&P 500 index (^GSPC 0.43%) is offering a tiny 1.1% dividend yield today. The average pharmaceutical stock yields around 1.7%. Bristol Myers Squibb (BMY +2.08%), however, is offering investors a yield of 4%. If you're a dividend investor…
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM EST
The Show Will Also Air Across Latin America and MENA 1230 pm local time. New to The Street will broadcast nationally tonight at 6:30 PM EST on Bloomberg Television, featuring executive leadership interviews with Medicus Pharma Ltd. (NASDAQ:MDCX)…
Monashee Investment Management LLC Lowers Holdings in BridgeBio Pharma, Inc. $BBIO
Monashee Investment Management LLC lessened its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 21.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange…
Urogen Pharma (NASDAQ:URGN) Given Consensus Rating of 'Moderate Buy' by Analysts
Urogen Pharma (NASDAQ:URGN - Get Free Report) has been assigned an average recommendation of 'Moderate Buy' from the eight research firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell…
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Short Interest Update
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) saw a large decline in short interest during the month of February. As of February 13th, there was short interest totaling 125,617 shares, a decline of 40.3% from the January 29th…
The trap Anthropic built for itself
Friday afternoon, just as this interview was getting underway, a news alert flashed across my computer screen: the Trump administration was severing ties with Anthropic, the San Francisco AI company founded in 2021 by Dario Amodei and other former…
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?
Eli Lilly (LLY +2.93%) is growing very quickly right now thanks to Mounjaro and Zepbound, its two GLP-1 drugs, the latter of which is approved for weight loss. Mounjaro's sales rose 99% in 2025, and Zepbound's sales were up a shocking 175%. But…
Erasca, Inc. (ERAS): A Bull Case Theory
We came across a bullish thesis on Erasca, Inc. on Danny's Substack by Danny Green. In this article, we will summarize the bulls' thesis on ERAS. Erasca, Inc.'s share was trading at $12.39 as of February 19th. Photo by National Cancer Institute on…
UBS Raises Viatris (VTRS) Price Target as Cost Savings and Growth Outlook Improve
Viatris Inc. (NASDAQ: VTRS) is included among the 13 Best March Dividend Stocks to Buy. On February 27, UBS raised its price recommendation on Viatris Inc. (NASDAQ:VTRS) to $20 from $18. It maintained a Buy rating on the stock. The firm noted that…
River Road Loads Up on ATR With 917,000 Shares in New Position
According to a Securities and Exchange Commission (SEC) filing dated February 24, 2026, River Road Asset Management, LLC established a new position in AptarGroup (ATR +1.35%) by acquiring 917,670 shares. The estimated value of this trade is $111.92…
PM Modi Targets Congress, Says Oppn Party Worked as 'Speedbreaker' in Puducherry's Growth
Puducherry: Prime Minister Narendra Modi, on Sunday, took aim at the Congress and said that the opposition party had created a 'speedbreaker in the growth of Puducherry'. Years of Congress rule were marked by corruption, crime and suffering of the…
Alabama Hospital Price Transparency: Only 54% Offer A Cost Calculator
Hospital price transparency is difficult to accomplish in real time. Americans are drowning in unpredictable healthcare bills, yet the federal push for hospital price transparency—meant to let patients shop like savvy consumers—often…
Bandu's Blockbusters For March 1, 2026
On April 1, four years ago, piqued by the incessant jokes in the village at his expense, Bandu Barve decided he'd had enough. It was time for him to turn ‘smart'. His dead granny's voice rang in his ears — “Read the papers…
Good Stock Picking Gives This Primecap Odyssey Fund a Lift
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up. Contact me with news and offers from other Future brands…
Rafferty Asset Management LLC Sells 6,156 Shares of Regeneron Pharmaceuticals, Inc. $REGN
Rafferty Asset Management LLC reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 11.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission…
Receive a Daily briefing on Pharma Industry News
Get Started